F257-2150 Screening compound: N-(2-{5-[(4-methoxyphenoxy)methyl]-1,2,4-oxadiazol-3-yl}ethyl)-5-(4-methoxyphenyl)-N-methyl-1,3-oxazole-4-carboxamide

F257-2150 Screening compound: N-(2-{5-[(4-methoxyphenoxy)methyl]-1,2,4-oxadiazol-3-yl}ethyl)-5-(4-methoxyphenyl)-N-methyl-1,3-oxazole-4-carboxamide
F257-2150 Screening compound: N-(2-{5-[(4-methoxyphenoxy)methyl]-1,2,4-oxadiazol-3-yl}ethyl)-5-(4-methoxyphenyl)-N-methyl-1,3-oxazole-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F257-2150
N-(2-{5-[(4-methoxyphenoxy)methyl]-1,2,4-oxadiazol-3-yl}ethyl)-5-(4-methoxyphenyl)-N-methyl-1,3-oxazole-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F257-2150

Molecular Formula

C24H24N4O6 (C24 H24 N4 O6)

Compound Name

N-(2-{5-[(4-methoxyphenoxy)methyl]-1,2,4-oxadiazol-3-yl}ethyl)-5-(4-methoxyphenyl)-N-methyl-1,3-oxazole-4-carboxamide

IUPAC name

N-(2-{5-[(4-methoxyphenoxy)methyl]-124-oxadiazol-3-yl}ethyl)-5-(4-methoxyphenyl)-N-methyl-13-oxazole-4-carboxamide

SMILES

CN(CCc1noc(COc(cc2)ccc2OC)n1)C(c1c(-c(cc2)ccc2OC)ocn1)=O

InChI

InChI=1S/C24H24N4O6/c1-28(24(29)22-23(33-15-25-22)16-4-6-17(30-2)7-5-16)13-12-20-26-21(34-27-20)14-32-19-10-8-18(31-3)9-11-19/h4-11,15H,12-14H2,1-3H3

InChI Key

HNMONQUGLAPRJA-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27110573

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

464.48

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

3.126

Distribution Coefficient, logD

3.126

Water Solubility, LogSw

-3.17

Polar Surface Area

90.124

Acid Dissociation Constant (pKa)

29.09

Base Dissociation Constant (pKb)

-1.91

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

25.00

F257-2150 in Drug Discovery

Included in Screening Libraries

Anti-Inflammatory Library (24602 compounds)

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with F257-2150 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F257-2150?
Check Price and Availability of F257-2150, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F257-2150 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F257-2150
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F257-2150
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F257-2150 available by request